Morgan Stanley noted Centene Corporation's underperformance compared to the broader market index on August 6, 2025.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley noted Centene Corporation's underperformance compared to the broader market index on August 6, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Centene Corporation
American multinational healthcare company
Nothing else this week.
Related events
- Analyst rating updates are affecting market perception for Morgan Stanley and Penn Entertainment.
- Morgan Stanley gave Micron Technology an overweight rating and included it in a list of major stocks.
- Morgan Stanley and Royal Bank of Canada adjusted ratings and price targets for TransDigm Group Incorporated stock.
- Morgan Stanley and CLSA are influencing stock prices through rating upgrades and downgrades.
- Financial firms, including Royal Bank of Canada, Santander Group, Lazard, and Morgan Stanley, upgraded ratings and increased holdings based on company performance.
Coverage
Newest first; wire copies grouped- BarchartCentene Stock: Is Wall Street Bullish or Bearish? Centene Corporation (CNC), headquartered in Saint Louis, Missouri, operates as a healthcare enterprise that provides programs and services to under-i